In March, Fujifilm had cut short enrolment in a Phase III trial, saying the emergence of the Omicron variant made it tough to measure the drug's effectiveness in preventing severe symptoms.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/dXNCtzi
0 Comments